1203649-61-9

Basic information

• Product Name: 5-(tert-Butoxycarbonyl)pyridine-3-boronic acid
• Synonyms: 5-(tert-Butoxycarbonyl)pyridine-3-boronic acid;(5-(tert-Butoxycarbonyl)pyridin-3-yl)boronic acid
• CAS NO: 1203649-61-9
• Molecular Formula: C10H14BNO4
• Molecular Weight: 223.03346
• Mol File: 1203649-61-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-(tert-Butoxycarbonyl)pyridine-3-boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(tert-Butoxycarbonyl)pyridine-3-boronic acid(1203649-61-9)
• EPA Substance Registry System: 5-(tert-Butoxycarbonyl)pyridine-3-boronic acid(1203649-61-9)

Safety Data

• Hazardous Substances Data: 1203649-61-9(Hazardous Substances Data)

Usage

General Description

5-(tert-Butoxycarbonyl)pyridine-3-boronic acid is a chemical compound that consists of a pyridine ring with a boronic acid and tert-butoxycarbonyl group attached to it. It is often used in organic synthesis as a reagent for creating carbon-carbon, carbon-oxygen, and carbon-nitrogen bonds. 5-(tert-Butoxycarbonyl)pyridine-3-boronic acid is known for its ability to form stable complexes with various ligands, making it a useful tool in the field of catalysis and medicinal chemistry. Additionally, 5-(tert-Butoxycarbonyl)pyridine-3-boronic acid has shown potential in the development of new pharmaceuticals and agrochemicals due to its versatile and reactive nature.

Upstream product

• 1309982-38-4 C₁₆H₂₄BNO₄ 

Downstream Products

• 1203649-62-0 tert-butyl 5-[2,6-diethoxy-4-(methoxycarbonyl)phenyl]nicotinate 

Relevant articles and documents

NOVEL SPIROCHROMANONE CARBOXYLIC ACIDS

The invention relates to a compound of a general formula (I): wherein A represents a linking group; Ar1 represents a group formed from an aromatic ring; R1 and R2 each independently represent a hydrogen atom, a halogen atom, a cyano group, a C2-C6 alkenyl group, a C1-C6 alkoxy group, a halo-C1-C6 alkoxy group, a cyclo-C3-C6 alkyloxy group, a C2-C7 alkanoyl group, a halo-C2-C7 alkanoyl group, a C2-C7 alkoxycarbonyl group, a halo-C2-C7 alkoxycarbonyl group, a cyclo-C3-C6 alkyloxycarbonyl group, an aralkyloxycarbonyl group, a carbamoyl-C1-C6 alkoxy group, a carboxy-C2-C6 alkenyl group, or a group of -Q1-N(Ra)-Q2-Rb; a C1-C6 alkyl group optionally having substituent(s); an aryl or heterocyclic group optionally having substituent(s); or a C1-C6 alkyl group or a C2-C6 alkenyl group having the aryl or heterocyclic group; T and U each independently represent a nitrogen atom or a methine group; and V represents an oxygen atom, a sulfur atom or an imino group. The compound of the invention is useful as therapeutical agents for various ACC-related diseases.